Julian Gabor

1.1k total citations
15 papers, 398 citations indexed

About

Julian Gabor is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Julian Gabor has authored 15 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 6 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Julian Gabor's work include Malaria Research and Control (6 papers), Mosquito-borne diseases and control (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Julian Gabor is often cited by papers focused on Malaria Research and Control (6 papers), Mosquito-borne diseases and control (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Julian Gabor collaborates with scholars based in Germany, Gabon and South Africa. Julian Gabor's co-authors include Peter G. Kremsner, Martin P. Grobusch, Bertrand Lell, Norbert Georg Schwarz, Saadou Issifou, Meral Esen, Lutz P. Breitling, Robert D. Newman, Sélidji Todagbé Agnandji and Adrian J. F. Luty and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Julian Gabor

14 papers receiving 394 citations

Peers

Countries citing papers authored by Julian Gabor

Since Specialization

Citations

This map shows the geographic impact of Julian Gabor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julian Gabor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julian Gabor more than expected).

Fields of papers citing papers by Julian Gabor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julian Gabor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julian Gabor. The network helps show where Julian Gabor may publish in the future.

Co-authorship network of co-authors of Julian Gabor

This figure shows the co-authorship network connecting the top 25 collaborators of Julian Gabor. A scholar is included among the top collaborators of Julian Gabor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julian Gabor. Julian Gabor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster 2024 ·Vaccines ·Meral Esen, (unknown), Julian Gabor, (unknown), (unknown), (unknown), (unknown), Sabine Bélard, Carlos Lamsfus Calle, Tamirat Gebru Woldearegai, (unknown), (unknown), (unknown), (unknown), Markus Löffler, (unknown), (unknown), Michael Ramharter, Ralf Amann, Peter G. Kremsner	3
2	Erkrankungen bei Tropenrückkehrern 2022 ·PubMed Central ·(unknown), Julian Gabor, (unknown)	0
3	Aetiologies and clinical presentation of central nervous system infections in Vietnamese patients: a prospective study 2022 ·Scientific Reports ·Julian Gabor, (unknown), Bùi Tiến Sỹ, (unknown), (unknown), Nguyen Trong The, Salih Kuk, Peter G. Kremsner, Christian G. Meyer, Lê Hữu Song, Thirumalaisamy P. Velavan	5
4	Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients 2021 ·Scientific Reports ·Thirumalaisamy P. Velavan, Salih Kuk, Le Thi Kieu Linh, Carlos Lamsfus Calle, Albert Lalremruata, Srinivas Reddy Pallerla, Andrea Kreidenweiss, Jana Held, Meral Esen, Julian Gabor, (unknown), (unknown), Anahita Fathi, Erwin Biecker, Christoph P. Berg, Michael Ramharter, Marylyn M. Addo, Benno Kreuels, Peter G. Kremsner	11
5	Longitudinal Monitoring of Lactate in Hospitalized and Ambulatory COVID-19 Patients 2021 ·American Journal of Tropical Medicine and Hygiene ·Thirumalaisamy P. Velavan, Le Thi Kieu Linh, Andrea Kreidenweiss, Julian Gabor, Sanjeev Krishna, Peter G. Kremsner	21
6	Dengue and chikungunya seroprevalence in Gabonese infants prior to major outbreaks in 2007 and 2010: A sero-epidemiological study 2016 ·Travel Medicine and Infectious Disease ·Julian Gabor, Norbert Georg Schwarz, Meral Esen, Peter G. Kremsner, Martin P. Grobusch	18
7	Influenza A and Parvovirus B19 Seropositivity Rates in Gabonese Infants 2015 ·American Journal of Tropical Medicine and Hygiene ·Julian Gabor, Norbert Georg Schwarz, Meral Esen, Peter G. Kremsner, Martin P. Grobusch	2
8	Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial 2013 ·The Lancet Infectious Diseases ·Philipp Zanger, Dennis Nurjadi, Julian Gabor, (unknown), Peter G. Kremsner	24
9	Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years 2013 ·BMC Infectious Diseases ·Dorothee Kieninger, Eric Sheldon, Wen‐Yuan Lin, Chong‐Jen Yu, José M. Bayas, Julian Gabor, Meral Esen, (unknown), Silvia Narejos Pérez, (unknown), Yang Feng, Carine Claeys, Mathieu Peeters, Bruce L. Innis, Varsha Jain	86
10	High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children 2011 ·Malaria Journal ·Ghyslain Mombo‐Ngoma, Sunny Oyakhirome, Rosalynn Ord, Julian Gabor, (unknown), (unknown), (unknown), Florian Kurth, Bertrand Lell, Jürgen F. J. Kun, Saadou Issifou, Cally Roper, Peter G. Kremsner, Martin P. Grobusch	29
11	A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon 2011 ·Malaria Journal ·Matthias Frank, (unknown), Pembé Issamou Mayengué, Julian Gabor, (unknown), (unknown), Ghyslain Mombo‐Ngoma, Christian Supan, Bertrand Lell, Francine Ntoumi, Martin P. Grobusch, Klaus Dietz, Peter G. Kremsner	36
12	No Rebound of Morbidity Following Intermittent Preventive Sulfadoxine‐Pyrimethamine Treatment of Malaria in Infants in Gabon 2009 ·The Journal of Infectious Diseases ·Martin P. Grobusch, Julian Gabor, John J. Aponte, Norbert Georg Schwarz, (unknown), (unknown), Katharina Schuster, (unknown), (unknown), (unknown), Florian Kurth, Peter Pongratz, Saadou Issifou, Bertrand Lell, Peter G. Kremsner	13
13	Reasons for non-adherence to vaccination at mother and child care clinics (MCCs) in Lambaréné, Gabon 2009 ·Vaccine ·Norbert Georg Schwarz, Marjolein Gysels, Christopher Pell, Julian Gabor, (unknown), Saadou Issifou, Bertrand Lell, Peter G. Kremsner, Martin P. Grobusch, Robert Pool	29
14	Placental Malaria Increases Malaria Risk in the First 30 Months of Life 2008 ·Clinical Infectious Diseases ·Norbert Georg Schwarz, Ayôla Akim Adégnika, Lutz P. Breitling, Julian Gabor, Sélidji Todagbé Agnandji, Robert D. Newman, Bertrand Lell, Saadou Issifou, Maria Yazdanbakhsh, Adrian J. F. Luty, Peter G. Kremsner, Martin P. Grobusch	102
15	Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon 2008 ·Malaria Journal ·Jürgen May, Samuel Adjei, Wibke Busch, Julian Gabor, Saadou Issifou, Robin Kobbe, Benno Kreuels, Bertrand Lell, Norbert Georg Schwarz, Ohene Adjei, Peter G. Kremsner, Martin P. Grobusch	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact